Smart Innovation
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Researchers and Entrepreneurs who wish to investigate, develop and commercialize novel vaccines, diagnostics and antimicrobials to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Researchers at Universities and University Medical Centers
- Researchers at Research Institutes
- R&D professionals in Pharma, Biopharma and Diagnostics companies
- Entrepreneurs in start-up’s and spin off companies
- Innovators, Venture Capitalists.
Latest Topics
-
30 October 2025The applications and advantages of nanopore sequencing in bacterial antimicrobial resistance surveillance and research
This review paper examines how long-read nanopore sequencing technology is transforming bacterial antimicrobial resistance (AMR) research and surveillance. It highlights that nanopore devices deliver ultra-long DNA reads and real-time sequencing, enabling detailed assembly of whole bacterial genomes, rapid detection of antimicrobial resistance genes (ARGs), and analysis of their genomic context (e.g., mobile elements, plasmids). These […]
Read more... -
28 October 2025Phage-antibiotics synergy and nanotechnology interventions in the management of drug resistance among bacterial pathogens: A scoping review
This review highlights innovative strategies to combat rising antibiotic resistance, focusing on the combined use of bacteriophages, antibiotics, and nanotechnology. While phage therapy shows strong potential against resistant bacteria, its application is limited by factors like stability and targeted delivery. Combining phages with antibiotics enhances antibacterial effects even at low doses, and nanotechnology further improves […]
Read more... -
24 October 2025Navigating and Advancing Market Access for In Vitro Diagnostics: Understanding the Roles of Key Stakeholders and Policy
The article argues that for in-vitro diagnostics (IVDs) to meaningfully support antimicrobial stewardship and combat antimicrobial resistance, it’s not enough just to develop good tests — manufacturers, regulators, payors, clinicians, laboratories and patient advocates must all coordinate on evidence generation, regulatory pathways, reimbursement strategies, and advocacy. It outlines the complex landscape of market access — […]
Read more...
More news related to Smart innovation
